Todd Brown, MD, PhD







  •     Member, Bone Complications Working Group of the Inflammation TSG 08/19/08-Present
  •     Member, Immune Activation Focus Group of Inflammation TSG, 04/01/14-Present
  •     Member, Inflammation TSG
  •     Member, Exercise Focus Group of the Inflammation TSG, 03/25/14-Present
  •     Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  •     Protocol Vice-Chair, ACTG 5280, ACTG 5303
  •     Co-chair, ACTG 5361s
  •     Co-investigator, ACTG 5257


Leadership Committees

Clinical Trials

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5128: Consent for Use of Stored Patient Specimens for...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More